E-Prescribing Market Share, Size, Trends, Industry Analysis Report, By Delivery Mode (Cloud Based, Web Based, and On-Premise); By Prescription Type; By End Use; By Region; Segment Forecast, 2023-2032
The global e-prescribing market size is expected to reach USD 16,069.01 million by 2032, according to a new study by polaris market research. The report “E-Prescribing Market Share, Size, Trends, Industry Analysis Report, By Delivery Mode (Cloud Based, Web Based, and On-Premise); By Prescription Type; By End Use; By Region; Segment Forecast, 2023-2032” gives a detailed insight into the current market dynamics and provides analysis on future market growth.
E-prescribing market is being fueled by a variety of factors, such as government initiatives and incentives, greater adoption of electronic health record solutions, the need to reduce medication errors, and rising healthcare costs. E-prescribing systems provide a number of advantages over traditional paper-based prescription systems, including enhanced patient safety, decreased errors and medication-related adverse events, increased efficiency, and improved communication between healthcare providers and pharmacists.
Implementation of e-prescriptions in the Polish healthcare system was intended to address the issue of illegible prescriptions and improve patient treatment outcomes. As a result, patient safety is expected to improve by decreasing the likelihood of incorrect medication dispensing. These examples point towards substantial market growth over the forecast period. Additionally, some of the key trends in the market include the increasing use of mobile health technologies and telehealth services to facilitate remote prescribing, the integration of e-prescribing with other digital health tools such as clinical decision support systems and patient portals, and the growing use of artificial intelligence and machine learning algorithms to help identify potential medication errors and drug interactions.
In February, 2023, eClinicalWorks, the biggest ambulatory cloud EHR, announced that Redding Gastroenterology had switched to the intelligent eClinicalWorks Cloud for increased interoperability and 24/7 secure patient data access. By developing a single patient record and strengthening data storage and security, this deployment will assist the practice in providing unified care. The use of an intelligent EHR system and increased interoperability can certainly facilitate the process of e-prescribing and other digital health tools. With a single patient record and secure data access, providers can more easily and accurately prescribe medications and monitor potential drug interactions.
COVID-19 pandemic has had a significant impact on the market. Healthcare providers are increasingly turning to digital health technologies such as e-prescribing to provide safe and efficient care in the face of social distancing and other public health measures. As a result, there has been a surge in the adoption of e-prescribing, and telehealth services, which frequently include e-prescribing capabilities, are being offered by many healthcare providers.
E-Prescribing Market Report Highlights
Cloud-based will dominate the market in the projected period. The primary factor driving the market is the fact that cloud-based e-prescribing solutions have many benefits over conventional on premise solutions, including usability, scalability, and accessibility.
Hospitals dominated the market in 2022. The rising usage of integrated EHR solutions that include e-prescribing capabilities is one of the main factors driving market growth.
The North America will account for largest share during forecast period. The primary cause for market growth is attributable to many reasons, including increased acceptance of healthcare IT solutions and the presence of well-established healthcare infrastructure.
Global players include eClinicalWorks, Surescripts, Practice Fusion, Athenahealth, Henry Schein Medical, & Change Healthcare.
Polaris Market Research has segmented the e-prescribing market report based on delivery mode, prescription type, end use and region:
E-Prescribing, Delivery Mode Outlook (Revenue - USD Million, 2019 - 2032)
Cloud Based
Web Based
On-Premise
E-Prescribing, Prescription Type Outlook (Revenue - USD Million, 2019 - 2032)
Controlled substance
Non controlled Substances
E-Prescribing, End use Outlook (Revenue - USD Million, 2019 - 2032)
Physician’s Office
Hospitals
Pharmacies
E-Prescribing, Regional Outlook (Revenue - USD Million, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa